Alexa Fluor® 700 anti-mouse Ly-6G Antibody

Pricing & Availability
Clone
1A8 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus G
Isotype
Rat IgG2a, κ
1A8_AF700_072210
C57BL/6 bone marrow cells stained with 1A8 Alexa Fluor® 700
  • 1A8_AF700_072210
    C57BL/6 bone marrow cells stained with 1A8 Alexa Fluor® 700
Compare all formats See Alexa Fluor® 700 spectral data
Cat # Size Price Quantity Check Availability
127621 25 µg $116.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
127622 100 µg $248.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.

Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Ly-6G transfected EL-4J cell line.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 700 under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
IHC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Alexa Fluor® 700 has a maximum emission of 719 nm when it is excited at 633 nm / 635 nm. Prior to using Alexa Fluor® 700 conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Red Laser (633 nm)
Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416.

Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References

(PubMed link indicates BioLegend citation)
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
  2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
  3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
  4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
  5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
  6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
  7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
  8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
  10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
  11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
  12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
  13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
  14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
  15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
  17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
  19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
  20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Gallizioli M, et al. 2020. Cell Rep. 33:108291. PubMed
  2. Sauter M, et al. 2022. STAR Protoc. 3:101664. PubMed
  3. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  4. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  5. Fukuzaki Y, et al. 2023. iScience. 26:106340. PubMed
  6. Kaur N, et al. 2023. Heliyon. 9:e14952. PubMed
  7. Arora S, et al. 2023. PLoS One. 18:e0286211. PubMed
  8. Zengel J, et al. 2023. Nat Methods. . PubMed
  9. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
  10. Pierson M, et al. 2021. Curr Protoc. 1:e53. PubMed
  11. Woods PS, et al. 2022. Elife. 11: . PubMed
  12. Millar FR, et al. 2022. Cell Rep. 41:111596. PubMed
  13. Blomberg OS 2023. Cancer Cell. 41(1):106-123.e10. PubMed
  14. Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed
  15. Feng J, et al. 2022. Immunity. 55:405. PubMed
  16. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  17. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  18. Lyons J, et al. 2018. PLoS Biol. 16:e2002417. PubMed
  19. Dong L, et al. 2021. Cancer Cell. . PubMed
  20. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  21. Hreha TN, et al. 2020. Front Immunol. 1.597916667. PubMed
  22. Haertel E, et al. 2018. Eur J Immunol. 48:1001. PubMed
  23. Esmaili S, et al. 2021. Cell Systems. 12(5):432-445.e7. PubMed
  24. Salas–Pérdomo A, et al. 2019. Sci Rep. 9:8309. PubMed
  25. Ma C, et al. 2018. Science. 360:eaan5931. PubMed
  26. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  27. Tuit S, et al. 2019. Cell Rep. 29:1221. PubMed
  28. Lyons J, et al. 2018. Sci Signal. 11. PubMed
  29. Liang P, et al. 2022. Mol Biomed. 3:14. PubMed
  30. Zhang Y, et al. 2015. PLoS Pathog. 11: e1005167. PubMed
  31. Mainz RE, et al. 2022. Cells. 11:. PubMed
  32. Lin J, et al. 2017. Sci Rep. 7:41722. PubMed
  33. Hartwig T et al. 2018. Cell reports. 25(13):3564-3572 . PubMed
  34. Stewart JM, et al. 2020. ACS Biomater Sci Eng. 6:5941. PubMed
  35. Pascual–García M, et al. 2019. Nat Commun. 10:2416. PubMed
  36. Lu CY, et al. 2020. J Neurosci. 40:9602. PubMed
  37. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  38. Ahadome S, et al. 2016. JCI Insight. 1:e87012. PubMed
  39. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  40. Kren N, et al. 2020. Sci Rep. 10:7390. PubMed
  41. Lewis EL, et al. 2021. Front Immunol. 12:741518. PubMed
  42. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  43. Toomey CB, et al. 2018. Invest Ophthalmol Vis Sci. 59:662. PubMed
  44. Da Silva CG, et al. 2019. Theranostics. 4.878472222. PubMed
  45. Krueger A, et al. 2022. Front Microbiol. 12:789042. PubMed
  46. Gilbert NM, et al. 2021. Biol Open. 10:. PubMed
  47. Toomey C, et al. 2015. Proc Natl Acad Sci U S A. 112:3040. PubMed
  48. Jin C, et al. 2019. Cell. 176:998. PubMed
  49. Uderhardt S, et al. 2019. Cell. 177:541. PubMed
  50. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  51. Echevarría-Vargas IM, et al. 2018. EMBO Mol Med. 10:e8446. PubMed
  52. Tang Q, et al. 2021. Immunity. 54:1961. PubMed
  53. Godwin MS, et al. 2019. JCI Insight. 4:e126070. PubMed
  54. Otxoa–de–Amezaga A, et al. 2019. Stroke. 50:1548. PubMed
  55. Youshani AS, et al. 2019. J Neuroinflammation. 16:25. PubMed
  56. Soberanes S et al. 2018. Cell metabolism. 29(2):335-347 . PubMed
  57. Nalbandian A, et al. 2017. Inflammation. 40:21:00. PubMed
  58. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  59. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  60. Molgora M, et al. 2020. Cell. 182:886. PubMed
  61. Walsh CM, et al. 2019. Elife. 8:e48448. PubMed
  62. Grube J, et al. 2022. Cell Death Dis. 13:704. PubMed
  63. Freed-Pastor WA, et al. 2021. Cancer Cell. 39:1342. PubMed
  64. E O’Koren, R Mathew, D Saban 2016. Sci Rep. 6:20636. PubMed
  65. Smith R, et al. 2016. J Leukoc Biol. 100:371-80. PubMed
  66. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  67. Celorrio M, et al. 2022. Acta Neuropathol Commun. 10:10. PubMed
  68. Flak MB, et al. 2020. J Clin Invest. 130:359. PubMed
  69. Chen D, et al. 2021. JCI Insight. 6:. PubMed
  70. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  71. Avgustinova A, et al. 2021. Cell Stem Cell. . PubMed
  72. Ito Y, et al. 2021. Cell Reports. 35(4):109052. PubMed
  73. Di Liberto G et al. 2018. Cell. 175(2):458-471 . PubMed
  74. Fearon AE, et al. 2021. iScience. 24:103143. PubMed
  75. Matei DE, et al. 2021. Med (N Y). 2:864. PubMed
RRID
AB_10643269 (BioLegend Cat. No. 127621)
AB_10643269 (BioLegend Cat. No. 127622)

Antigen Details

Structure
A 21-35 kD GPI-anchorded membrane protein
Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type
Granulocytes, Macrophages, Monocytes
Biology Area
Immunology, Innate Immunity
Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID
546644 View all products for this Gene ID
UniProt
View information about Ly-6G on UniProt.org

Other Formats

View All Ly-6G Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse Ly-6G 1A8 IHC-F,SB
Purified anti-mouse Ly-6G 1A8 FC,IHC-F,IHC-P,SB
Biotin anti-mouse Ly-6G 1A8 FC,IHC
FITC anti-mouse Ly-6G 1A8 FC
PE anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 647 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Pacific Blue™ anti-mouse Ly-6G 1A8 FC
APC anti-mouse Ly-6G 1A8 FC
PerCP/Cyanine5.5 anti-mouse Ly-6G 1A8 FC
PE/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 700 anti-mouse Ly-6G 1A8 FC,IHC
APC/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 488 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Brilliant Violet 421™ anti-mouse Ly-6G 1A8 FC,IHC-F
Brilliant Violet 570™ anti-mouse Ly-6G 1A8 FC
Ultra-LEAF™ Purified anti-mouse Ly-6G 1A8 FC,Depletion,IHC
Brilliant Violet 510™ anti-mouse Ly-6G 1A8 FC
Purified anti-mouse Ly-6G (Maxpar® Ready) 1A8 FC,CyTOF®,WB
Brilliant Violet 650™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 711™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 605™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 785™ anti-mouse Ly-6G 1A8 FC
PE/Dazzle™ 594 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 750 anti-mouse Ly-6G 1A8 FC
PerCP anti-mouse Ly-6G 1A8 FC
TotalSeq™-A0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-C0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-B0015 anti-mouse Ly-6G 1A8 PG
Spark Blue™ 550 anti-mouse Ly-6G 1A8 FC
Spark NIR™ 685 anti-mouse Ly-6G 1A8 FC
Spark YG™ 593 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
PE/Cyanine5 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
Spark UV™ 387 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 640 anti-mouse Ly-6G 1A8 FC
Spark YG™ 570 anti-mouse Ly-6G 1A8 IHC-F,FC
Spark Red™ 718 anti-mouse Ly-6G (Flexi-Fluor™) 1A8 FC
Spark Blue™ 574 anti-mouse Ly-6G (Flexi-Fluor™) 1A8 FC
Go To Top Version: 4    Revision Date: 01/06/2017

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Login/Register
Forgot your password? Reset Password
Request an Account